Starbucks is ending GLP-1 coverage for weight loss as employer costs climb

In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees. The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。